Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Capital/Financing Update 2014

Nov 2, 2014

65124_rns_2014-11-02_06e85281-49bf-4129-8fe9-bd6acb43b27f.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [104 x 96] intentionally omitted <==

MARKET RELEASE

3 November 2014

Imugene Limited

TRADING HALT

The securities of Imugene Limited (the “Company”) will be placed in Trading Halt Session State at the request of the Company, pending the release of an announcement by the Company. Unless ASX decides otherwise, the securities will remain in Trading Halt Session State until the earlier of the commencement of normal trading on Wednesday, 5 November 2014 or when the announcement is released to the market.

Security Code:

IMU

Jill Hewitt Senior Adviser, Listings Compliance (Perth)

Page 1 of 1

==> picture [227 x 49] intentionally omitted <==

3 November 2014

Jill Hewitt ASX Compliance Pty Ltd Perth WA

Dear Jill Hewitt

**Trading

Halt Request**

Pursuant to ASX Listing Rule 17.1, Imugene Limited (Company) requests a trading halt pending an announcement in relation to a proposed capital raising.

The trading halt will remain in place until the earlier of the commencement of normal trading on Wednesday 5 November 2014, or until the release of the announcement in respect of the above matter.

The Company is not aware of any reason why the trading halt should not be granted.

Yours faithfully

==> picture [54 x 54] intentionally omitted <==

Justyn Stedwell Company Secretary Imugene Limited

Imugene Limited A.C.N: 009 179 551 Suite 1, 1233 High Street, Armadale, VIC, 3142 Phone: 03 9824 5254 Fax: 03 9822 7735